• Jeffrey L. Cummings
  • Dag Årsland
  • Lissy Jarvik


Elderly people may manifest a variety of behavioral syndromes produced by brain dysfunction, including multiple deficits in the delirious and dementia syndromes or single deficits in amnestic and aphasic disorders. In addition, brain lesions may cause “productive” behavioral syndromes, such as anxiety, delusions, hallucinations, depression, mania, and personality alterations. These disorders are not mutually exclusive: delirium may be superimposed on dementia and is frequently accompanied by anxiety, delusions, and/or mood changes; demented patients may manifest personality alterations, delusions, or mood alterations in addition to their intellectual deficits; personality changes often develop in patients with amnesia; and patients with aphasia may exhibit delusions or mood disorders that result from their underlying disease.


Human Immunodeficiency Virus Single Photon Emission Compute Tomography Progressive Supranuclear Palsy Dementia Syndrome Chronic Meningitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
  2. 2.
    Chedru F, Geschwind N. Disorders of higher cortical function in acute confusional states. Cortex. 1972; 8: 395–411.PubMedGoogle Scholar
  3. 3.
    Lipowski ZJ. Delirium (acute confusional states). JAMA. 1987; 258: 1789–1792.PubMedCrossRefGoogle Scholar
  4. 4.
    Rabins PV, Folstein MF. Delirium and dementia: diagnostic criteria and fatality rates. Br J Psychiatry. 1982; 140: 149–153.PubMedCrossRefGoogle Scholar
  5. 5.
    Masterman DL, Craig AH, Cummings JL. Alzheimer’s Disease. In: Gabbard G ed, Treatments of Psychiatric Disorders, 2nd ed. American Psychiatric Press: Washington, DC; 1995: 479–513.Google Scholar
  6. 6.
    Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL. A comparison of psychiatric symptoms in vascular dementia and Alzheimer’s disease. Am J Psychiatry. 1993; 150: 1806–1812.PubMedGoogle Scholar
  7. 7.
    Cummings JL. Organic delusions: phenomenology, anatomical correlations, and review. Br J Psychiatry. 1985; 146: 184–197.PubMedCrossRefGoogle Scholar
  8. 8.
    Peden JG, Jr., Kathol R. Mood disorders and general medical illness. In: Gabbard G ed, Treatments of Psychiatric Disorders. 2nd ed. American Psychiatric Press: Washington, DC; 1995: 1329–1348.Google Scholar
  9. 9.
    Cummings JL. Clinical Neuropsychiatry. New York: Grune & Stratton; 1985.Google Scholar
  10. 10.
    Kauf er D, Cummimgs JL. Personality alterations in degenerative brain diseases. In: Ratey JJ, ed, Neuropsychiatry of Personality Disorders, Blackwell Scientific Publication, London; 1995: 172–209.Google Scholar
  11. 11.
    O’Brien JT, Levy R. Age associated memory impairment (editorial). Br Med J. 1992; 304: 5–6.CrossRefGoogle Scholar
  12. 12.
    Evans DA, Funkenstein H, Albert MS, et al. Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. JAMA. 1989; 261: 921–923.Google Scholar
  13. 13.
    Cummings JL, Benson DF. Dementia: A Clinical Approach. 2nd ed. Stoneham, MA: Weinemann-Butterworths; 1992.Google Scholar
  14. 14.
    Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993; 261: 921–923.Google Scholar
  15. 15.
    Kallmann FJ. Heredity in Health and Mental Disorder. New York: Norton; 1953.Google Scholar
  16. 16.
    Brietner JC, Gatz M, Bergem AL, et al. Use of twin cohorts for research in Alzheimer’s disease. Neurology. 1993; 43: 261–267.CrossRefGoogle Scholar
  17. 17.
    Ashall F, Goate AM. Role of the beta-amyloid precursor protein in Alzheimer’s disease. Trends Biochem Sei. 1994; 19: 42–46.CrossRefGoogle Scholar
  18. 18.
    Roth M, Tomlinson BE, Blessed G. The relationship between quantitative measures of dementia and of degenerative changes in the cerebral grey matter of elderly subjects. Proc R Soc Med. 1967; 60: 254–258.PubMedGoogle Scholar
  19. 19.
    McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS- ADRDA Work Group under the auspices of theGoogle Scholar
  20. Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984; 34: 939–944.Google Scholar
  21. 20.
    Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS- ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology. 1988; 38: 359–364.PubMedCrossRefGoogle Scholar
  22. 21.
    Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology. 1985; 35: 453–461.PubMedCrossRefGoogle Scholar
  23. 22.
    Chandra V, Bharucha NE, Schoenberg BS. Conditions associated with Alzheimer’s disease at death: case-control study. Neurology. 1986; 36: 209–211.PubMedCrossRefGoogle Scholar
  24. 23.
    Galasko D, Corey-Bloom J, Thal LJ. Monitoring progression in Alzheimer’s disease. J Am Geriatr Soc. 1991; 39: 932–942.PubMedGoogle Scholar
  25. 24.
    NIH (National Institutes of Health). Consensus Development Conference Statement. Differential diagnosis of dementing diseases. JAMA. 1987; 258: 3411–3416.Google Scholar
  26. 25.
    Prichard JW, Brass LM. New anatomical and functional imaging methods. Ann Neurol. 1992; 32: 395–400.PubMedCrossRefGoogle Scholar
  27. 26.
    Katzman R. Alzheimer’s disease. N Engl J Med. 1986; 314: 964–973.PubMedCrossRefGoogle Scholar
  28. 27.
    Brun A, Gustafson L. Distribution of cerebral degeneration in Alzheimer’s disease. Arch Psychiatr Nervenk. 1976; 223: 15–33.CrossRefGoogle Scholar
  29. 28.
    Whitehouse PJ, Price DL, Clark AW, et al. Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982; 215: 1237–1239.PubMedCrossRefGoogle Scholar
  30. 29.
    Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology. 1991; 41: 479–486.PubMedCrossRefGoogle Scholar
  31. 30.
    The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994; 57: 416–418.Google Scholar
  32. 31.
    Gustafsson L. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr. 1987; 6: 209–223.CrossRefGoogle Scholar
  33. 32.
    Albert ML, Feldman RG, Willis AG. The “subcortial dementia” of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1974; 37: 121–130.PubMedCrossRefGoogle Scholar
  34. 33.
    Martilla RJ. Epidemiology. In: Koller WC, ed. Handbook of Parkinson’s Disease. New York: Marcel Dekker; 1976.Google Scholar
  35. 34.
    Cummings JL. Intellectual impairment in Parkinson’s disease: clinical, biochemical, and pathologic correlates. J Geriatr Psychiartr Neurol. 1988; 1: 24–36.CrossRefGoogle Scholar
  36. 35.
    Chang Chui H, Perlmutter LS. Pathological correlates of dementia in Parkinson’s disease. In: Huber S, Cummings JL, eds. Neurobehavioral Aspects of Parkinson’s Disease. New York: Oxford University Press; 1992: 164–177.Google Scholar
  37. 36.
    Lewin R. Dramatic results with brain grafts. Science. 1987; 237: 245–247.PubMedCrossRefGoogle Scholar
  38. 37.
    Forstl H, Burns A, Luthert P, et al. The Lewy-body variant of Alzheimer’s disease. Clinical and pathological findings. Br J Psychiatry. 1993; 162: 385–392.PubMedCrossRefGoogle Scholar
  39. 38.
    Hayden MR. Huntington’s Chorea. New York: Springer- Verlag; 1981.CrossRefGoogle Scholar
  40. 39.
    Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington’s disease. Nature. 1983; 306: 234–238.PubMedCrossRefGoogle Scholar
  41. 40.
    Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Neurology. 1993; 43: 259–260.Google Scholar
  42. 41.
    Rosen WG, Terry RD, Fuld PA, et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol. 1980; 7: 486–488.PubMedCrossRefGoogle Scholar
  43. 42.
    Thompson TL II, Moran MG, Nies AS. Psychotropic drug use in the elderly. N Engl J Med. 1983; 308: 134–138.PubMedCrossRefGoogle Scholar
  44. 43.
    Cutting J. The relationship between Korsakov’s syndrome and “alcoholic dementia.” Br J Psychiatry. 1978; 132: 240–251.Google Scholar
  45. 44.
    Ron MA. Brain damage in chronic alcoholism: a neuropathologica, neuroradiological, and psychological review. Psychol Med. 1977; 7: 103–112.PubMedCrossRefGoogle Scholar
  46. 45.
    Price RW, Brew B, Sidtis J, et al. The brain in AIDS: central nervous system HIV-I infection and AIDS dementia complex. Science. 1987; 239: 586–592.CrossRefGoogle Scholar
  47. 46.
    Yarchoan R, Brouwers P, Spitzer AR, et al. Response of human-immunodeficiency-virus-associated neurological disease to 3’-azido-3’-deoxythymicine. Lancet. 1987; 20: 597–602.Google Scholar
  48. 47.
    Collings J, Palmer MS. Prion diseases in humans and their relevance to other neurodegenerative diseases. Dementia. 1993; 4: 178–185.Google Scholar
  49. 48.
    Brown P, Cathala F, Castaigne P, et al. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol. 1986; 20: 597–602.PubMedCrossRefGoogle Scholar
  50. 49.
    Gajdusek DC. Unconventional viruses and the origin and disappearances of kuru. Science. 197: 943–960.Google Scholar
  51. 50.
    Mahler ME, Cummings JL. Treatable dementias. West J Med. 1987; 146: 705–712.PubMedGoogle Scholar
  52. 51.
    Corsellis JAN. Postrumatic dementia. In: Katzman R, Terry RD, Bick KL, eds. Aging: Alzheimer’s Disease: Senile Dementia and Related Disorders. New York: Raven Press; 1973: 7.Google Scholar
  53. 52.
    Black PM. Idiopathic normal-pressure hydrocephalus: results of shunting in 62 patients. J Neurosurg. 1980; 52: 371–377.PubMedCrossRefGoogle Scholar
  54. 53.
    LaRue A, D’Elia LF, Clark EO, et al. Clinical tests of memory in dementia, depression, and healthy aging. Psychology Aging. 1986; 1: 69–77.CrossRefGoogle Scholar
  55. 54.
    Alexopoulos GS, Meyers BS, Young RC, Maitis S, Kakuma T. The course of geriatric depression with “reversible dementia”: a controlled study. Am J Psychiatry. 1993; 150: 1693–1699.PubMedGoogle Scholar
  56. 55.
    Rubin SM, Glasser ML, Werckle MA. The examination of physician’s awareness of dementing disorders. J Am Geriatr Soc. 1987; 35: 1051–1058.PubMedGoogle Scholar
  57. 56.
    Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189–198.PubMedCrossRefGoogle Scholar
  58. 57.
    Blessed, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968; 114: 797–811.Google Scholar
  59. 58.
    Kahn RL. Psychological aspects of aging. In: Rossman I, ed. Clinical Geriatrics. Philadelphia: JB Lippincott; 1971.Google Scholar
  60. 59.
    Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975; 23: 433–441.PubMedGoogle Scholar
  61. 60.
    Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardized instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986; 4149: 698–709.CrossRefGoogle Scholar
  62. 61.
    Hughes CP, Berg L, Danzinger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140: 566–572.PubMedCrossRefGoogle Scholar
  63. 62.
    Reisberg B, Ferris SH, DeLeon MJ, et al. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982; 139: 1136–1139.PubMedGoogle Scholar
  64. 63.
    Larson EB, Reifler BV, Featherstone HJ, et al. Dementia in elderly outpatients: a prospective study. Ann Intern Med. 1984; 100: 417–423.PubMedGoogle Scholar
  65. 64.
    Martin DC, Miller J, Kapoor W, et al. Clinical prediction rules for computed tomographic scanning in senile dementia. Arch Intern Med. 1987; 147: 77–80.PubMedCrossRefGoogle Scholar
  66. 65.
    Garber HJ, Weilburg JB, Buananno FS, et al. Use of magnetic resonance imaging in psychiatry. Am J Psychiatry. 1988; 145: 164–171.PubMedGoogle Scholar
  67. 66.
    Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol. 1987; 44: 258–262.PubMedCrossRefGoogle Scholar
  68. 67.
    Johnson KA, Mueller ST, Walshe TM, et al. Cerebral perfusion imaging in Alzheimer’s disease. Arch Neurol. 1987; 44: 165–168.PubMedCrossRefGoogle Scholar
  69. 68.
    Foster NL, Chase TN, Mansi L, et al. Cortical abnormalities in Alzheimer’s disease. Ann Neurol. 1984; 16: 649–654.PubMedCrossRefGoogle Scholar
  70. 69.
    Knapp MJ, Knopman DS, Soloman PR, et al. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer’s disease. JAMA. 1994; 271: 985–991.PubMedCrossRefGoogle Scholar
  71. 70.
    Gent M, Blakely JA, Easton JD, et al. The Canadian American ticlopidine study (CATS) in thromboembolic stroke. Lancet. 1989: 1215–1220.Google Scholar
  72. 71.
    Jarvik LF, Trader DW. Treatment of behavioral and mood changes. In: Aronson M, ed. Understanding Alzheimer’s Disease. New York: Charles Scribner’s Sons; 1988: 128–145.Google Scholar
  73. 72.
    Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriat Soc. 1990; 38: 553–563.PubMedGoogle Scholar
  74. 73.
    Yodufsky SC, Silver JM, Hales RE. Pharmacologic management of aggression in the elderly. J Clin Psychiatry. 1990; 51 (suppl): 22–28.Google Scholar
  75. 74.
    Teri L, Rabins P, Whitehouse P, et al. Management of behavior disturbance in Alzheimer’s disease: current knowledge and future directions. Alzheimer Dis Assoc Disord. 1992; 6: 77–88.PubMedCrossRefGoogle Scholar
  76. 75.
    Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Geron-tologist. 1980; 20: 649–655.CrossRefGoogle Scholar
  77. 76.
    NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA. 1992; 268: 1018–1024.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Jeffrey L. Cummings
  • Dag Årsland
  • Lissy Jarvik

There are no affiliations available

Personalised recommendations